Edwards falls after forecasting Q4 sales below expectations

Edwards Lifesciences

25/10/2024 13:43

** Shares of medical device maker Edwards Lifesciences
 EW.N  fall 1.8% to $69.10 premarket
    ** Late on Thursday, co forecast Q4 rev. between $1.33 bln
and $1.39 bln, below Wall Street estimates of $1.44 bln - LSEG
    ** EW's Q3 rev. of $1.35 bln fell short of estimates of
$1.52 bln
    ** However, co's Q3 adj. EPS of 67 cents beat estimates of
63 cents
    ** Up to last close, stock down 7.7% YTD

 (Reporting by Puyaan Singh)
 ((Puyaan.Singh@thomsonreuters.com;))